ACTIVE

Avanos Medical Belgium

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result1,6 M €-59,3 %over 1 year

Revenue53,9 M €-7,9 %over 1 year

Equity7,7 M €-55,1 %over 1 year

Workforce57,1 ETP+3,8 %over 1 year

Identity

Source · BCE/KBO

Avanos Medical Belgium is a Private limited company incorporated in 2014. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Zaventem. It employs on average 57,1 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0553.802.001
Incorporation: 13/06/2014
Legal form: Private limited company
Registered office: Da Vincilaan 1
1930 Zaventem · FlandreSee on map
Contributed capital: 4 012 400,00 €
Latest accounts: 31/12/2025
Average workforce: 57,1 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 17220Manufacture of household and sanitary goods and of toilet requisites 17220Manufacture of household and sanitary goods and of toilet requisites

Joint committees (1)

Signals

ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHigh revenue

Financials

Source · NBB, 11 filings

Trend over 9 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	53,9 M €	-7.9%	58,5 M €	-1.7%	59,5 M €	+4.7%	56,9 M €	+59.2%	35,7 M €
EBITDA	1,4 M €	-73.6%	5,4 M €	+101%	2,7 M €	+8.3%	2,5 M €	+34.2%	1,9 M €
Operating result	1,4 M €	-74.1%	5,3 M €	+122%	2,4 M €	+0.2%	2,4 M €	+50.3%	1,6 M €
Net result	1,6 M €	-59.3%	3,8 M €	+128%	1,7 M €	+2.0%	1,6 M €	+64.7%	995,6 k €
Balance sheet
Equity	7,7 M €	-55.1%	17,2 M €	-6.5%	18,3 M €	+10.0%	16,7 M €	+10.9%	15 M €
Total assets	39,2 M €	+2.5%	38,2 M €	+2.0%	37,5 M €	-0.3%	37,6 M €	+47.2%	25,5 M €
Cash	8,5 M €	+0.7%	8,4 M €	+23.6%	6,8 M €	+9.5%	6,2 M €	+20.6%	5,1 M €
Debts	31,2 M €	+50.7%	20,7 M €	+10.1%	18,8 M €	-8.3%	20,5 M €	+102%	10,1 M €
Other
Workforce	57,1 ETP	+3.8%	55,0 ETP	+6.2%	51,8 ETP	+9.3%	47,4 ETP	-6.1%	50,5 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 25 M€ and 50 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 16 ended

Active mandates

Dieter Krines

Director · since 02 janvier 2022

Active

Nancy Carine C. Vanderoost

Director · since 06 avril 2018

Active

Ended mandates

James Allsop

Director · since 10 juin 2019 · until 21 novembre 2021

Ended

James Allsop

Director · since 10 juin 2019

Ended

James Allsop

Manager · since 10 juin 2019

Ended

Sevinç Özdogan Schoenaerts

Manager · since 15 juin 2018 · until 10 juin 2019

Ended

Other companies at this address

Da Vincilaan 1 1930 Zaventem

Company	CBE no.
0x52● Active	0798.596.941
1 MILLION● Active	1003.924.462
3 STARS CONSTRUCTION● Active	0801.690.944
Acceleer● Active	1013.839.545
Achievers● Active	0734.749.660
ADD - APT● Active	0473.316.349
AD-MAX● Active	1022.723.260
ADVERPRESS● Active	0820.282.874
AEG SOLUTIONS● Active	1012.626.253
AGENCY IMMO CONSTRUCT● Active	0800.222.482
AGI EMEA● Bankrupt	0450.925.086
AKIKOL CONCEPT● Active	1016.135.871
ALASKA BAKKERIJ● Active	0804.161.276
ALB CONSTRUCT● Active	0802.549.591
ALE CREATIF CONSTRUCT● Active	0798.215.968
ALFA LAVAL BENELUX● Active	0401.864.664
ALISENN COMMUNICATIE● Active	0822.087.965
ALLINON● Active	1042.380.905
ALLROUND-SERVICES● Active	1005.722.130
American Transport● Active	0679.584.077

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	08/07/2026	04/07/2025	05/07/2024	04/07/2023	07/07/2022	01/07/2021
General meeting	30/06/2026	30/06/2025	28/06/2024	30/06/2023	30/06/2022	30/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 11 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	30/06/2026	08/07/2026	Dutch	PDF
Full model	31/12/2024	30/06/2025	04/07/2025	Dutch	PDF
Full model	31/12/2023	28/06/2024	05/07/2024	Dutch	PDF
Full model	31/12/2022	30/06/2023	04/07/2023	Dutch	PDF
Full model	31/12/2021	30/06/2022	07/07/2022	Dutch	PDF
Full model	31/12/2020	30/06/2021	01/07/2021	Dutch	PDF
Full model	31/12/2019	31/07/2020	12/08/2020	Dutch	PDF
Full model	31/12/2018	28/06/2019	30/08/2019	Dutch	PDF
Full model	31/12/2017	29/06/2018	10/07/2018	Dutch	PDF
Full model	31/12/2016	30/06/2017	24/07/2017	Dutch	PDF
Full model	31/12/2015	30/06/2016	12/07/2016	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 25 M€ and 50 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 16 ended

Active mandates

Dieter Krines

Director · since 02 janvier 2022

Active

Nancy Carine C. Vanderoost

Director · since 06 avril 2018

Active

Ended mandates

James Allsop

Director · since 10 juin 2019 · until 21 novembre 2021

Ended

James Allsop

Director · since 10 juin 2019

Ended

James Allsop

Manager · since 10 juin 2019

Ended

Sevinç Özdogan Schoenaerts

Manager · since 15 juin 2018 · until 10 juin 2019

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates03/09/2024
ONTSLAGEN - BENOEMINGEN
PDF
Other03/02/2022
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM
PDF
Mandates31/01/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates12/07/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates09/07/2019
ONTSLAGEN - BENOEMINGEN
PDF
Mandates30/04/2019
ONTSLAGEN - BENOEMINGEN
PDF
Mandates07/02/2019
ONTSLAGEN - BENOEMINGEN
PDF
Other04/02/2019
BENAMING
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 20251,6 M €↓
2024
Annual accounts 20243,8 M €↑
2023
Annual accounts 20231,7 M €↑
2022
Annual accounts 20221,6 M €↑
2021
Annual accounts 2021995,6 k €↓
2018
Annual accounts 20181,6 M €↓
2018
Name changeAvanos Medical Belgium
2017
Annual accounts 20172,5 M €↑
2016
Annual accounts 20161,6 M €↓
2015
Annual accounts 20152,6 M €
2015
Name changeHALYARD BELGIUM
13/06/2014
IncorporationPrivate limited company
28/06/2004
reconductionDeloitte Bedrijfsrevisoren BV — commissaris

Avanos Medical Belgium

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline